Tensions at COP29, UN's Climate Change Conference in Baku, resolved as governments agreed on a new collective annual climate ...
Novartis has secured European Commission approval for Kisqali® (ribociclib) in combination with endocrine therapy (ET) as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback